No Data
No Data
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
Express News | Fibrobiologics Inc -Agreement Term Expires on Sept 19, 2029, Unless Earlier Terminated by Either Party in Accordance With Agreement
Express News | Fibrobiologics Inc -on Sept 19, Entered Into a Master Services Agreement With Charles River Laboratories
FibreBiologics Shares Are Trading Higher After Maxim Group Initiated Coverage on the Stock With a Buy Rating and Announced a $12 Price Target.
Maxim Group Initiates FibroBiologics(FBLG.US) With Buy Rating, Announces Target Price $12
FibroBiologics Engages Southern Star Research as CRO in Australia
No Data
No Data